AAUM (Average Assets Under Management) of ₹299.44 Cr for Apr-Jun 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 64.7% | 65.7% | ▲ +1.0% |
| Healthcare Services | 28.9% | 28.3% | ▼ -0.6% |
| Insurance | 2.4% | 2.5% | ● +0.1% |
| IT - Services | 0.3% | 0.3% | ● 0.0% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 65.7% | 66.1% | ▲ +0.5% |
| Healthcare Services | 28.3% | 28.4% | ● +0.1% |
| Insurance | 2.5% | 1.0% | ▼ -1.5% |
| N.A. | 0.0% | 1.0% | ▲ +1.0% |
| IT - Services | 0.3% | 0.0% | ▼ -0.3% |
Comparing Jun 2026 → Jul 2026
| # | Stock | Sector | Weight (Jul 2026) |
|---|---|---|---|
| 1 | Torrent Pharmaceuticals Limited ₹14.37 Cr |
Pharmaceuticals & Biotechnology | 4.50% |
| 2 | Sai Parenterals Limited ₹3.10 Cr |
N.A. | 0.97% |
| # | Stock | Sector | Last Weight (Jun 2026) |
|---|---|---|---|
| 1 | JB Chemicals & Pharmaceuticals Limited ₹13.78 Cr |
Pharmaceuticals & Biotechnology | 4.27% |
| 2 | Star Health And Allied Insurance Company Limited ₹4.71 Cr |
Insurance | 1.46% |
| 3 | Inventurus Knowledge Solutions Limited ₹83.97 L |
IT - Services | 0.26% |
| # | Stock | Sector | Jun 2026 | Jul 2026 | Change |
|---|---|---|---|---|---|
| 1 | Novartis India Limited ₹4.91 Cr |
Pharmaceuticals & Biotechnology | 0.44% | 1.54% | +1.10% |
| 2 | Sun Pharmaceutical Industries Limited ₹34.83 Cr |
Pharmaceuticals & Biotechnology | 10.11% | 10.91% | +0.80% |
| 3 | Thyrocare Technologies Limited ₹4.63 Cr |
Healthcare Services | 0.68% | 1.45% | +0.77% |
| 4 | Global Health Limited ₹11.53 Cr |
Healthcare Services | 2.85% | 3.61% | +0.76% |
| 5 | Dr. Lal Path Labs Limited ₹11.05 Cr |
Healthcare Services | 2.96% | 3.46% | +0.50% |
| 6 | Sequent Scientific Limited ₹2.45 Cr |
Pharmaceuticals & Biotechnology | 0.36% | 0.77% | +0.41% |
| 7 | Apollo Hospitals Enterprise Limited ₹26.87 Cr |
Healthcare Services | 8.08% | 8.41% | +0.33% |
| 8 | GlaxoSmithKline Pharmaceuticals Limited ₹7.97 Cr |
Pharmaceuticals & Biotechnology | 2.28% | 2.49% | +0.21% |
| 9 | Abbott India Limited ₹6.95 Cr |
Pharmaceuticals & Biotechnology | 1.97% | 2.18% | +0.21% |
| 10 | Rainbow Childrens Medicare Limited ₹7.63 Cr |
Healthcare Services | 2.19% | 2.39% | +0.20% |
| # | Stock | Sector | Jun 2026 | Jul 2026 | Change |
|---|---|---|---|---|---|
| 1 | Max Healthcare Institute Limited ₹10.99 Cr |
Healthcare Services | 6.30% | 3.44% | -2.86% |
| 2 | Divi's Laboratories Limited ₹12.89 Cr |
Pharmaceuticals & Biotechnology | 6.12% | 4.04% | -2.08% |
| 3 | Dr. Reddy's Laboratories Limited ₹11.48 Cr |
Pharmaceuticals & Biotechnology | 4.21% | 3.59% | -0.62% |
| 4 | Concord Biotech Limited ₹1.42 Cr |
Pharmaceuticals & Biotechnology | 0.79% | 0.44% | -0.35% |
| 5 | Shilpa Medicare Ltd ₹7.95 Cr |
Pharmaceuticals & Biotechnology | 2.78% | 2.49% | -0.29% |
| 6 | Eris Lifesciences Limited ₹6.13 Cr |
Pharmaceuticals & Biotechnology | 2.01% | 1.92% | -0.09% |
| 7 | Medi Assist Healthcare Services Ltd ₹3.22 Cr |
Insurance | 1.02% | 1.01% | -0.01% |
34 stocks — Jul 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹34.83 Cr |
Pharmaceuticals & Biotechnology |
10.91%
|
|
| 2 |
₹26.87 Cr |
Healthcare Services |
8.41%
|
|
| 3 |
₹22.10 Cr |
Pharmaceuticals & Biotechnology |
6.92%
|
|
| 4 |
₹14.37 Cr |
Pharmaceuticals & Biotechnology |
4.50%
|
|
| 5 |
₹12.89 Cr |
Pharmaceuticals & Biotechnology |
4.04%
|
|
| 6 |
₹12.64 Cr |
Pharmaceuticals & Biotechnology |
3.96%
|
|
| 7 |
₹11.53 Cr |
Healthcare Services |
3.61%
|
|
| 8 |
₹11.48 Cr |
Pharmaceuticals & Biotechnology |
3.59%
|
|
| 9 |
₹11.17 Cr |
Pharmaceuticals & Biotechnology |
3.50%
|
|
| 10 |
₹11.05 Cr |
Healthcare Services |
3.46%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.